80 related articles for article (PubMed ID: 17108690)
1. Histological and immunohistological changes of the skeletal muscles in older SJL/J mice.
Nemoto H; Konno S; Nakazora H; Miura H; Kurihara T
Eur Neurol; 2007; 57(1):19-25. PubMed ID: 17108690
[TBL] [Abstract][Full Text] [Related]
2. Anti-TNF therapy using etanercept suppresses degenerative and inflammatory changes in skeletal muscle of older SJL/J mice.
Nemoto H; Konno S; Sugimoto H; Nakazora H; Nomoto N; Murata M; Kitazono H; Fujioka T
Exp Mol Pathol; 2011 Jun; 90(3):264-70. PubMed ID: 21324312
[TBL] [Abstract][Full Text] [Related]
3. Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B.
Bittner RE; Anderson LV; Burkhardt E; Bashir R; Vafiadaki E; Ivanova S; Raffelsberger T; Maerk I; Höger H; Jung M; Karbasiyan M; Storch M; Lassmann H; Moss JA; Davison K; Harrison R; Bushby KM; Reis A
Nat Genet; 1999 Oct; 23(2):141-2. PubMed ID: 10508505
[No Abstract] [Full Text] [Related]
4. Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model.
Farini A; Sitzia C; Navarro C; D'Antona G; Belicchi M; Parolini D; Del Fraro G; Razini P; Bottinelli R; Meregalli M; Torrente Y
Exp Cell Res; 2012 Jun; 318(10):1160-74. PubMed ID: 22465227
[TBL] [Abstract][Full Text] [Related]
5. Dysferlin-deficient muscular dystrophy: gadofluorine M suitability at MR imaging in a mouse model.
Schmidt S; Vieweger A; Obst M; Mueller S; Gross V; Gutberlet M; Steinbrink J; Taubert S; Misselwitz B; Luedemann L; Spuler S
Radiology; 2009 Jan; 250(1):87-94. PubMed ID: 19001151
[TBL] [Abstract][Full Text] [Related]
6. Experimental allergic myositis in SJL/J mouse. Reappraisal of immune reaction based on changes after single immunization.
Matsubara S; Kitaguchi T; Kawata A; Miyamoto K; Yagi H; Hirai S
J Neuroimmunol; 2001 Oct; 119(2):223-30. PubMed ID: 11585625
[TBL] [Abstract][Full Text] [Related]
7. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.
Ho M; Post CM; Donahue LR; Lidov HG; Bronson RT; Goolsby H; Watkins SC; Cox GA; Brown RH
Hum Mol Genet; 2004 Sep; 13(18):1999-2010. PubMed ID: 15254015
[TBL] [Abstract][Full Text] [Related]
8. The distribution and characterization of skeletal muscle lesions in dysferlin-deficient SJL and A/J mice.
Kobayashi K; Izawa T; Kuwamura M; Yamate J
Exp Toxicol Pathol; 2010 Sep; 62(5):509-17. PubMed ID: 19615872
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of MHC class I expression accompanies but is not required for spontaneous myopathy in dysferlin-deficient SJL/J mice.
Kostek CA; Dominov JA; Miller JB
Am J Pathol; 2002 Mar; 160(3):833-9. PubMed ID: 11891182
[TBL] [Abstract][Full Text] [Related]
10. Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle.
Spencer MJ; Montecino-Rodriguez E; Dorshkind K; Tidball JG
Clin Immunol; 2001 Feb; 98(2):235-43. PubMed ID: 11161980
[TBL] [Abstract][Full Text] [Related]
11. Human umbilical cord blood cells differentiate into muscle in sjl muscular dystrophy mice.
Kong KY; Ren J; Kraus M; Finklestein SP; Brown RH
Stem Cells; 2004; 22(6):981-93. PubMed ID: 15536189
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of class II MHC antigens by skeletal muscle endothelial cells in experimental autoimmune myositis.
Rosenberg NL; Kotzin BL
J Immunol; 1989 Jun; 142(12):4289-94. PubMed ID: 2656863
[TBL] [Abstract][Full Text] [Related]
13. Expression profiling with progression of dystrophic change in dysferlin-deficient mice (SJL).
Suzuki N; Aoki M; Hinuma Y; Takahashi T; Onodera Y; Ishigaki A; Kato M; Warita H; Tateyama M; Itoyama Y
Neurosci Res; 2005 May; 52(1):47-60. PubMed ID: 15811552
[TBL] [Abstract][Full Text] [Related]
14. Dysferlin and the plasma membrane repair in muscular dystrophy.
Bansal D; Campbell KP
Trends Cell Biol; 2004 Apr; 14(4):206-13. PubMed ID: 15066638
[TBL] [Abstract][Full Text] [Related]
15. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells.
Tago F; Tsukimoto M; Nakatsukasa H; Kojima S
Radiat Res; 2008 Jan; 169(1):59-66. PubMed ID: 18159952
[TBL] [Abstract][Full Text] [Related]
16. SJL dystrophic mice express a significant amount of human muscle proteins following systemic delivery of human adipose-derived stromal cells without immunosuppression.
Vieira NM; Bueno CR; Brandalise V; Moraes LV; Zucconi E; Secco M; Suzuki MF; Camargo MM; Bartolini P; Brum PC; Vainzof M; Zatz M
Stem Cells; 2008 Sep; 26(9):2391-8. PubMed ID: 18583542
[TBL] [Abstract][Full Text] [Related]
17. Distinct effects of contraction-induced injury in vivo on four different murine models of dysferlinopathy.
Roche JA; Ru LW; Bloch RJ
J Biomed Biotechnol; 2012; 2012():134031. PubMed ID: 22431915
[TBL] [Abstract][Full Text] [Related]
18. Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis.
Jacobo P; Guazzone VA; Jarazo-Dietrich S; Theas MS; Lustig L
J Reprod Immunol; 2009 Jul; 81(1):44-54. PubMed ID: 19520436
[TBL] [Abstract][Full Text] [Related]
19. A new murine model to define the critical pathologic and therapeutic mediators of polymyositis.
Sugihara T; Sekine C; Nakae T; Kohyama K; Harigai M; Iwakura Y; Matsumoto Y; Miyasaka N; Kohsaka H
Arthritis Rheum; 2007 Apr; 56(4):1304-14. PubMed ID: 17394136
[TBL] [Abstract][Full Text] [Related]
20. Defective membrane repair in dysferlin-deficient muscular dystrophy.
Bansal D; Miyake K; Vogel SS; Groh S; Chen CC; Williamson R; McNeil PL; Campbell KP
Nature; 2003 May; 423(6936):168-72. PubMed ID: 12736685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
